Spinocerebellar Ataxia Type 7: A Neurodegenerative Disorder with Peripheral Neuropathy

被引:10
|
作者
Salas-Vargas, Jose [1 ]
Mancera-Gervacio, Jocelyn [2 ]
Velazquez-Perez, Luis [6 ]
Rodrigez-Labrada, Roberto [6 ]
Martinez-Cruz, Emilio [1 ]
Magana, Jonathan J. [3 ]
Durand-Rivera, Alfredo [2 ]
Hernandez-Hernandez, Oscar [3 ]
Cisneros, Bulmaro [4 ]
Gonzalez-Pina, Rigoberto [2 ,5 ]
机构
[1] Ctr Rehabil & Inclus Social Veracruz, Xalapa, Veracruz, Mexico
[2] IPN, CINVESTAV, Div Neurociencias, Ciudad Mexico, DF, Mexico
[3] IPN, CINVESTAV, Inst Nacl Rehabil, Dept Genet, Ciudad Mexico, DF, Mexico
[4] IPN, CINVESTAV, Dept Genet & Biol Mol, Ciudad Mexico, DF, Mexico
[5] Univ Amer AC, Mexico City, DF, Mexico
[6] Ctr Invest & Rehabil Ataxias, Hereditarias, Holguin, Cuba
关键词
Spinocerebellar ataxia type 7; Neuropathy; Peripheral nerves; Neurophysiology; DOMINANT CEREBELLAR ATAXIAS; MACHADO-JOSEPH-DISEASE; MEXICAN POPULATION; BRAZILIAN FAMILIES; PHENOTYPE; SCA7; DYSTROPHY; FEATURES;
D O I
10.1159/000370239
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Autosomal dominant spinocerebellar ataxias (SCA) are a group of inherited neurodegenerative disorders that typically show peripheral neuropathy. SCA7 is one of the rarest forms of SCA (<1/100,000 individuals). However, the disease shows a prevalence of similar to 800/100,000 inhabitants in certain regions of Mexico. This low global prevalence may explain, at least in part, the isolated anecdotal and limited clinical data regarding peripheral neuropathy in SCA7 patients. Aim: To assess sensory and motor peripheral nerve action potentials in an SCA7 patients group and in healthy volunteers, and subsequently correlate the electrophysiological findings with clinical and genetic features. Materials and Methods: We enrolled in our study, 13 symptomatic SCA7 patients with a confirmed molecular and clinical diagnosis, and 19 healthy volunteers as the control group. Nerve conduction studies were carried out using standard electromyography recording methods. The sensory and motor latency, amplitude and conduction velocity were recorded in both experimental groups and analyzed using the Student's t-test. Results: SCA7 patients showed a significant prolongation of sensory nerve conduction latencies, as well as a decrease in sensory amplitudes. Decreases in motor amplitudes and peroneal conduction velocity were also observed. Finally, we found an association between CAG repeats and the severity of cerebellar and non-cerebellar symptoms with electrophysiological signs of demyelinization. Discussion: Our results reveal the existence of a critical sensorimotor peripheral neuropathy in SCA7 patients. Moreover, we show that using sensitive electrophysiological tools to evaluate nerve conduction can improve the diagnosis and design of therapeutic options based on pharmacological and rehabilitative strategies. Conclusion: These findings demonstrate that SCA7 is a disease that globally affects the peripheral nervous system. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [31] Spinocerebellar Ataxia 3 (SCA3) Patient with Peripheral Neuropathy
    Aminah, Siti
    Pusparini, Lin
    Lailiyya, Nushrotul
    Ganiem, Ahrnad Rizal
    Gamayani, Uni
    Wibisono, Yusuf
    Huda, Fathul
    Sribudiani, Yunia
    Achmad, Tri Hanggono
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2022, 54 (01): : 57 - 62
  • [32] Respiratory neuropathology in spinocerebellar ataxia type 7
    Biswas, Debolina D.
    Shi, Yihan
    El Haddad, Lea
    Sethi, Ronit
    Huston, Meredith
    Kehoe, Sean
    Scarrow, Evelyn R.
    Strickland, Laura M.
    Pucci, Logan A.
    Dhindsa, Justin S.
    Hunanyan, Ani
    La Spada, Albert R.
    ElMallah, Mai K.
    JCI INSIGHT, 2024, 9 (18)
  • [33] Ophthalmic features of spinocerebellar ataxia type 7
    A Campos-Romo
    E O Graue-Hernandez
    L Pedro-Aguilar
    J C Hernandez-Camarena
    D Rivera-De la Parra
    V Galvez
    R Diaz
    A Jimenez-Corona
    J Fernandez-Ruiz
    Eye, 2018, 32 : 120 - 127
  • [34] Sensory Neuropathy in Spinocerebellar Ataxia Type 14: A Novel Phenotype
    Nashi, Saraswati
    Singh, Raviprakash
    Menon, Deepak
    Arshad, Faheem
    Alladi, Suvarna
    Mahale, Rohan
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2023, 26 (04) : 591 - 593
  • [35] Neuropathy in spinocerebellar ataxia type 1, 2, 3 and 6
    Linnemann, C.
    du Montcel, S. Tezenas
    Rakowicz, M.
    Schmitz-Huebsch, T.
    Szymanski, S.
    Berciano, J.
    Van de Warrenburg, B. P.
    Depondt, C.
    Rola, R.
    Klockgether, T.
    Garcia, A.
    Mutlu, G.
    Schols, L.
    MOVEMENT DISORDERS, 2010, 25 (07) : S194 - S194
  • [36] Assessment of Peripheral Neuropathy Using Current Perception Threshold Measurement in Patients with Spinocerebellar Ataxia Type 3
    Liu, Xia-Hua
    Lin, Wei
    Xu, Hao-Ling
    Cui, Mao-Lin
    Huang, Zhuo-Ying
    Li, Ying
    Zhang, Nan-Nan
    Wang, Ning
    Wang, Zhi-Yong
    Gan, Shi-Rui
    OSCCAR Investigators
    CEREBELLUM, 2025, 24 (02):
  • [37] Genetic Modeling of the Neurodegenerative Disease Spinocerebellar Ataxia Type 1 in Zebrafish
    Elsaey, Mohamed A.
    Namikawa, Kazuhiko
    Koester, Reinhard W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [38] Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7
    Pacheco, Laura A. Pesantez
    Thakur, Nivedita
    ANNALS OF NEUROLOGY, 2020, 88 : S195 - S196
  • [39] Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy
    Higuchi, Yujiro
    Okunushi, Ryuta
    Hara, Taichi
    Hashiguchi, Akihiro
    Yuan, Junhui
    Yoshimura, Akiko
    Murayama, Kei
    Ohtake, Akira
    Ando, Masahiro
    Hiramatsu, Yu
    Ishihara, Satoshi
    Tanabe, Hajime
    Okamoto, Yuji
    Matsuura, Eiji
    Ueda, Takehiro
    Toda, Tatsushi
    Yamashita, Sumimasa
    Yamada, Kenichiro
    Koide, Takashi
    Yaguchi, Hiroaki
    Mitsui, Jun
    Ishiura, Hiroyuki
    Yoshimura, Jun
    Doi, Koichiro
    Morishita, Shinichi
    Sato, Ken
    Nakagawa, Masanori
    Yamaguchi, Masamitsu
    Tsuji, Shoji
    Takashima, Hiroshi
    BRAIN, 2018, 141 : 1622 - 1636
  • [40] Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7
    Pacheco, L. Pesantez
    Thakur, N.
    MOVEMENT DISORDERS, 2020, 35 : S22 - S22